Notice of Exempt Solicitation. Definitive Material. (px14a6g)
March 29 2021 - 10:57AM
Edgar (US Regulatory)
AbbVie Inc (ABBV)
Shareholder Alert
Voluntary submission by John Chevedden,
POB 2673, Redondo Beach, CA 90278.
ABBV Shareholder
Vote for Management Proposal # 5:
Management Proposal
to Eliminate Supermajority Voting
Management failed to mention that a
rule 14a-8 shareholder proposal was submitted for the 2021 shareholder meeting on the same topic as this management proposal.
The 2021 shareholder proposal was necessary
because management failed to obtain an 80% vote from all the shares outstanding for its own proposal on the same topic in 2019. And it
failed by a relatively small margin. The 2021 shareholder proposal was superseded by the 2021 management proposal # 5 on the same topic.
Management does not seem to have much
enthusiasm for its own proposal so it makes it necessary for me, a small shareholder, to urge a yes-vote for the management proposal.
It is especially important to get a high shareholder voting turnout for this proposal because it needs an 80% vote from all shares outstanding.
If a shareholder sits out this election it is the same as a vote against vote this management proposal.
And failure to get an 80%-vote for
this proposal has a cascading bad outcome. It prevents us shareholders from voting on each director every year. This could have a
further cascading bad outcome because if the chair of the ABBV management pay committee is lavish with CEO pay it could take shareholders
3-years to have an opportunity to vote against that lavish director. Meanwhile AbbVie CEO Richard Gonzalez scored $24 million in 2020
pay – up 11%.
Urging shareholders to vote for this
proposal should be the job of Mr. Edward Rapp, the chair of the ABBV Governance Committee. Instead
this job seems to default to me.
Perhaps Mr. Rapp
could share some of his ABBV $360,000 paycheck with me. And Mr. Rapp would seem to have enough time to work on getting shareholders
to cast ballots since Mr. Rapp does not seem to have had a day job since age 58. Shareholders can check the “Against All”
box regarding the election of 4 directors to send a message that the 5th vote on proposal 5 will finally go over the 80% threshold
needed.
ABBV has failed 4-times since 2017 to
obtain an 80% vote needed for management proposals for a long overdue improvements in ABBV’s outdated governance rules.
Perhaps Mr. Rapp can learn from the
management of another company which likewise needed to obtain a high percentage vote from all shares outstanding. This company said:
• We intend to undertake
an aggressive outreach program to all elements of our shareholder base to encourage them to vote for management’s supermajority
vote proposal.
• This will be done through direct
solicitation of institutional and hedge fund investors as well as a campaign to maximize favorable voting by retail holders to the greatest
extent feasible through frequent reminder mailings with proxy cards and a telephone calling campaign.
• We also will be engaging with
proxy advisors and expect that they will recommend for management’s proposal.
Please vote for Management
Proposal 5 which would remove the existing 80% supermajority vote requirements. This would pave the way for annual election of
each director.
Written materials are submitted
pursuant to Rule 14a-6(g)(1) promulgated under the Securities Exchange Act of 1934.*
*Submission is not required of this
filer under the terms of the Rule, but is made voluntarily in the interest of public disclosure and consideration of these important
issues.
This is not a solicitation of authority to vote your proxy. Please DO NOT send me your proxy card; the shareholder is not able
to vote your proxies, nor does this communication contemplate such an event.
The shareholder asks all shareholders to vote their choices by following the procedural instructions provided in the proxy materials.
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Mar 2024 to Apr 2024
AbbVie (NYSE:ABBV)
Historical Stock Chart
From Apr 2023 to Apr 2024